| Basics |
|
Akoya BioSciences, Inc.
|
| IPO Date: |
April 12, 2021 |
| Sector: |
Healthcare |
| Industry: |
Medical Instruments and Supplies |
| Market Cap: |
$67.44M |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.27 | 3.40%
|
| Avg Daily Range (30 D): |
$0.06 | 4.20%
|
| Avg Daily Range (90 D): |
$0.05 | 4.12%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.18M |
| Avg Daily Volume (30 D): |
.05M |
| Avg Daily Volume (90 D): |
.28M |
| Trade Size |
| Avg Trade Size (Sh.): |
100 |
| Avg Trade Size (Sh.) (30 D): |
144 |
| Avg Trade Size (Sh.) (90 D): |
167 |
| Institutional Trades |
| Total Inst.Trades: |
108 |
| Avg Inst. Trade: |
$1.97M |
| Avg Inst. Trade (30 D): |
$2.53M |
| Avg Inst. Trade (90 D): |
$2.53M |
| Avg Inst. Trade Volume: |
.17M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.85M |
| Avg Closing Trade (30 D): |
$2.53M |
| Avg Closing Trade (90 D): |
$2.53M |
| Avg Closing Volume: |
215.61K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.96
|
$-.32
|
$-.16
|
|
Diluted EPS
|
$-.96
|
$-.32
|
$-.16
|
|
Revenue
|
$ 79.96M
|
$ 16.64M
|
$ 21.34M
|
|
Gross Profit
|
$ 49.37M
|
$ 9.87M
|
$ 14.39M
|
|
Net Income / Loss
|
$ -47.53M
|
$ -15.65M
|
$ -8.2M
|
|
Operating Income / Loss
|
$ -38.56M
|
$ -13.41M
|
$ -5.71M
|
|
Cost of Revenue
|
$ 30.59M
|
$ 6.77M
|
$ 6.96M
|
|
Net Cash Flow
|
$ 7.31M
|
$ 8.58M
|
$ -.78M
|
|
PE Ratio
|
|
|
|
|
|
|